| Document Date: 2014-11-06 11:32:51
Open Document File Size: 309,48 KBShare Result on Facebook
City Reference / / Company Helsinki Heart Study1 Group / / Country Finland / / Event Product Issues / Product Recall / / Facility Attend clinic / / IndustryTerm chemical name / chemical / / MedicalCondition abdominal pain / cholecystitis / basal cell carcinoma / adenomas / GALLBLADDER DISEASE / cancer / CHD / tumors / disease / Cataracts / cholelithiasis / myopathy / hypothyroidism / leukopenia / liver neoplasms / hepatocellular carcinoma / hypertriglyceridemia / Carcinogenesis / dysfunction / chronic / basal cell carcinomas / dyslipidemia / thrombocytopenia / familial hypertriglyceridemia / hyperlipidemia / rhabdomyolysis / fatal and nonfatal myocardial infarctions / renal insufficiency / myocardial infarction / nonfatal myocardial infarction / diabetes mellitus / myositis / Diseases / pancreatitis / angina / Hypersensitivity / myoglobinuria / coronary heart disease / myocardial infarctions / carcinomas / primary biliary cirrhosis / hypoglycemia / acute renal failure / anemia / gallstones / Anophthalmia / / MedicalTreatment gallbladder surgery / adjunctive therapy / Concomitant therapy / Estrogen therapy / Drug therapy / surgery / / Organization World Health Organization / Federal Communications Commission / / Product triad / itraconazole / simvastatin / LOPID / polyethylene glycol / Gemfibrozil / fenofibrate / repaglinide / clofibrate / / Technology pharmacokinetics / artificial intelligence / /
SocialTag |
LOPID (Gemfibrozil Tablets, USP) DESCRIPTION LOPID® (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for